Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Senior Managing Editor
Vice President, Editorial
Clinical Care Options, LLC
This activity is intended for physicians and other healthcare providers involved in the care of patients infected with hepatitis C.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 27, 2012, through February 26, 2013:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Expert commentary from W. David Hardy, MD, featuring guidance on HCV screening and treatment as prevention in MSM, provided by Clinical Care Options
Commentary by Marta Torrens, MD, from Spain on eliminating HCV by optimizing diagnosis, treatment access, and follow-up in high-risk populations.
Expert overview of recommendations on the management of patients with HCV infection.
Alain H. Litwin, MD, provides expert insights on models of care that can expand linkage to HCV treatment and cure as well as contribute to overall improved health outcomes for persons who inject drugs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.